Overall survival in advanced hepatocellular carcinoma treated with concomitant systemic therapy and stereotactic body radiation therapy or systemic therapy alone.

Piening, Alexander; Swaminath, Anand; Dombrowski, John; Teague, Ryan M; Al-Hammadi, Noor; Shahi, Jeevin

Piening, Alexander; Swaminath, Anand; Dombrowski, John; Teague, Ryan M; Al-Hammadi, Noor; Shahi, Jeevin.

Afiliação

Piening A; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Swaminath A; Department of Radiation Oncology, McMaster University, Hamilton, ON, Canada.
Dombrowski J; Department of Radiation Oncology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Teague RM; Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Al-Hammadi N; Department of Health and Clinical Outcomes Research, Advanced HEAlth Data (AHEAD) Research Institute, Saint Louis University School of Medicine, St. Louis, MO, United States.
Shahi J; Department of Radiation Oncology, Saint Louis University School of Medicine, St. Louis, MO, United States.

Front Oncol ; 13: 1290691, 2023.

Article em En | MEDLINE | ID: mdl-38090505